Are you looking for expert advice...

Cannabis & Neurological Conditions: A Clinical Overview

Categories: Neurology

About Course

Presented by Professor Mike Barnes, Cannabis & Neurological Conditions: A Clinical Overview provides an in-depth clinical overview of the role of cannabis-based medicines in the treatment of neurological conditions.

Designed for healthcare professionals, the module explores evidence-based approaches to symptom management across a range of disorders including multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, Tourette’s syndrome, Huntington’s disease, dystonia, glioblastoma and traumatic brain injury.

Whether you’re new to prescribing or looking to deepen your knowledge, this course delivers essential guidance rooted in the latest clinical experience and data.

Members of the Society can access a discount code reducing the price of this course to £100. This is available via the Member’s Hub and is non-transferable. 

Show More

What Will You Learn?

  • Understand how cannabis-based medicines can support symptom control in neurological conditions.
  • Recognise the best evidence areas, including spasticity, neuropathic pain, anxiety, and sleep.
  • Explore the potential role of cannabis in neurodegenerative disorders such as Alzheimer’s and Parkinson’s.
  • Review emerging evidence in movement disorders (Tourette’s, Huntington’s, dystonia, Parkinson’s).
  • Learn about cannabis use in glioblastoma and its possible impact on survival outcomes.
  • Gain insight into the neuroprotective potential of cannabis in conditions such as traumatic brain injury.
  • Apply safe prescribing principles – start low, go slow, and adjust THC:CBD ratios according to symptoms.
  • Learn about mechanisms of action, dosing strategies, and practical prescribing considerations for each condition – including when to consider cannabis medicines, how to tailor treatment to symptom clusters, and how to navigate clinical uncertainties.

Course Content

Introduction & Learning Objectives

  • Learning Objectives
    02:22

Spasticity

Multiple Sclerosis

Parkinson’s Disease

Alzheimer’s Disease

Tourette’s Syndrome

Huntington’s Disease

Dystonia

Glioblastoma and Traumatic Brain Injury (TBI)

Summary & Key Takeaways

Student Ratings & Reviews

No Review Yet
No Review Yet